Skip to main content
ChemoMetec logo

ChemoMetec — Investor Relations & Filings

Ticker · CHEMM ISIN · DK0060055861 LEI · 213800533NBKECGONO68 CO Manufacturing
Open in API
Filings indexed 540 across all filing types
Latest filing 2026-05-15 Transaction in Own Shar…
Country DK Denmark
Listing CO CHEMM

About ChemoMetec

https://chemometec.com

ChemoMetec is a global manufacturer specializing in high-precision automated cell counting and analysis instrumentation. The company develops and produces a range of advanced image cytometers and cell density analyzers, including the NucleoCounter® and XcytoMatic® series. These systems provide consistent, reproducible, and accurate cell count and viability data for a wide range of cell types. Key technologies include fluorescence microscopy, which enables trypan blue-free analysis, and specialized consumables designed to minimize human error. ChemoMetec's instruments are designed for regulated environments, offering software solutions compliant with FDA 21 CFR Part 11 and supporting Good Manufacturing Practice (GMP) workflows. The company serves customers in the biotechnology, pharmaceutical, and academic sectors, with applications in cell and gene therapy, cancer research, and bioprocessing.

Recent filings

Filing Released Lang Actions
Initiation of buy-back programme
Transaction in Own Shares Classification · 91% confidence The document is a formal company announcement detailing the initiation of a share repurchase program (buyback): authorization, size (up to 500,000 shares/2.9%), period, pricing framework, and broker arrangements—all indicators of a transaction in the company’s own shares. This matches the definition for share buyback/issuance (POS).
2026-05-15 Danish
Initiation of buy-back programme
Transaction in Own Shares Classification · 95% confidence The document is a formal announcement by ChemoMetec A/S of the initiation of a share buy-back programme, detailing the repurchase period, maximum number of shares, and financial parameters. It does not present full financial statements or an earnings summary but specifically reports on the company purchasing its own shares. This matches the definition of “Transaction in Own Shares” (Code: POS).
2026-05-15 English
Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance
Capital/Financing Update Classification · 95% confidence The document is a short announcement (1954 characters) about an adjustment in accounting estimates affecting revenue and EBITDA forecasts for the fiscal year 2025/26. It provides updated financial guidance but does not contain detailed financial statements or comprehensive financial data. It also references a forthcoming quarterly report but does not include the report itself. The document is essentially a capital/financial update informing the market about changes in financial expectations due to accounting adjustments. Therefore, it fits best under Capital/Financing Update (CAP).
2026-05-04 Danish
Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance
Capital/Financing Update Classification · 90% confidence The document is an announcement dated 4 May 2026 from ChemoMetec regarding an adjustment of accounting estimates that leads to an upgrade of revenue and operating profit guidance. It provides updated financial guidance figures for the 2025/26 financial year and mentions a forthcoming trading statement for Q3 2025/26. The document is relatively short (2072 characters) and does not contain detailed financial statements or comprehensive financial data. It is primarily an update on financial guidance and accounting estimate adjustments rather than a full financial report or earnings release. Given the nature of the content—an update on financial guidance and accounting estimates without detailed financial results or statements—this fits best under Capital/Financing Update (CAP), which covers updates on company financial outlook and related adjustments. It is not an earnings release (ER) because it does not present actual quarterly results, nor is it a full interim or annual report. Therefore, the classification is CAP with high confidence.
2026-05-04 English
Notification of managers’ transactions
Director's Dealing Classification · 95% confidence The document is a regulatory form filed with the Danish Financial Supervisory Authority (Finanstilsynet) detailing a transaction in the company’s own shares by a person with management responsibility (CFO Kim Nicolajsen). It provides insider share transaction details (date, number of shares, price, venue), which matches the definition of a Director’s Dealing report (insider trades by executives). Therefore, the correct classification is DIRS.
2026-03-27 Danish
Notification of managers’ transactions
Director's Dealing Classification · 92% confidence The document is a notification of transactions in company shares by persons with management responsibility under EU regulation 596/2014 (insider transactions). This matches the definition of Director’s Dealing (Code: DIRS): reports of personal share transactions by company directors and executives.
2026-03-27 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.